secwatch.observer — SEC 8-K summary
======================================

Issuer:     Edesa Biotech, Inc. (EDSA)
CIK:        0001540159
Form:       8-K
Filed at:   2026-05-29T20:15:18+00:00
Accession:  0001171843-26-003793
Event type: other
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Edesa Biotech shareholders approve equity plan amendment adding 750K shares
---------------------------------------------------------------------------

- Shareholders approved Plan Amendment increasing shares available for issuance by 750,000 and eliminating annual per participant option grant limit.
- All seven director nominees elected with over 2.6M votes for each; broker non-votes of ~2.15M on each.
- Advisory vote on executive compensation approved with 2.67M for, 69K against.
- Appointment of MNP LLP as auditors for FY2026 approved with 4.81M for.
- Approximately 55% of outstanding shares (4.9M shares) represented at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1540159/000117184326003793/0001171843-26-003793-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1540159/000117184326003793/f8k_052226.htm
  HTML page:      https://secwatch.observer/filing/0001171843-26-003793

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer